Unraveling the lost balance: Adrenergic dysfunction in cancer cachexia

Auton Neurosci. 2023 Dec 6;251:103136. doi: 10.1016/j.autneu.2023.103136. Online ahead of print.ABSTRACTCancer cachexia, characterized by muscle wasting and widespread inflammation, poses a significant challenge for patients with cancer, profoundly impacting both their quality of life and treatment management. However, existing treatment modalities remain very limited, accentuating the necessity for innovative therapeutic interventions. Many recent studies demonstrated that changes in autonomic balance is a key driver of cancer cachexia. This review consolidates research findings from investigations into autonomic dysfunction across cancer cachexia, spanning animal models and patient cohorts. Moreover, we explore therapeutic strategies involving adrenergic receptor modulation through receptor blockers and agonists. Mechanisms underlying adrenergic hyperactivity in cardiac and adipose tissues, influencing tissue remodeling, are also examined. Looking ahead, we present a perspective for future research that delves into autonomic dysregulation in cancer cachexia. This comprehensive review highlights the urgency of advancing research to unveil innovative avenues for combatting cancer cachexia and improving patient well-being.PMID:38071925 | DOI:10.1016/j.autneu.2023.103136
Source: Autonomic Neuroscience - Category: Neuroscience Authors: Source Type: research